HDAC9 and neoplasm: In this sense, HDAC inhibitors have been described as antineoplastic agents that promote the death of tumor cells by stimulating the expression of pro-apoptotic proteins, however, this effect is poorly defined in primary cell cultures [24,25,26]; in our study, neither TSA nor VPA induce significant changes in cell viability when they are used in unfractionated PBMCs.